New patent rules overturned

A Virginia court struck down today (April 1) linkurl:new patent rules;http://www.the-scientist.com/news/display/53497/ which pharma and biotech companies argued would have limited their ability to protect their intellectual property. The new rules, which were finalized by the US Patent and Trademark Organization (USPTO) last August, limit inventors to two continuing applications, which add claims to an existing patent, and cap the total number of claims in a patent at 25. "Specifically in lif

Alla Katsnelson
Mar 31, 2008
A Virginia court struck down today (April 1) linkurl:new patent rules;http://www.the-scientist.com/news/display/53497/ which pharma and biotech companies argued would have limited their ability to protect their intellectual property. The new rules, which were finalized by the US Patent and Trademark Organization (USPTO) last August, limit inventors to two continuing applications, which add claims to an existing patent, and cap the total number of claims in a patent at 25. "Specifically in life sciences that has a huge effect," Lisa Haile, a patent attorney and co-chair of the Global Life Sciences Sector at the law firm DLA Piper, told The Scientist, because the timeframe of life science discoveries is so long. Previously, inventors were allowed to file unlimited continuing applications. University-based inventors and biotech companies could file continuances as the scope of their discoveries became clearer with further research, and, for example, could extend patent coverage from one or two new...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?